Pregnant women who are taking antidepressants are at a 68% greater risk for miscarriage than women not taking the drugs, a nested, case-control study from Quebec reports.
Pregnant women who are taking antidepressants are at a 68% greater risk for miscarriage than women not taking the drugs, a nested, case-control study from Quebec reports.
Researchers included data on 5,124 women who had had clinically verified miscarriages up to 20 weeks' gestation and a large sample of women who had not miscarried. Of those who miscarried, 5.5% had taken at least 1 antidepressant during the pregnancy versus 2.7% of those who did not.
Use of a selective serotonin reuptake inhibitor increased the risk by about 61% (odds ratio [OR]. 1.61; 95% CI, 1.28-2.04). Serotonin-norepinephrine reuptake inhibitors more than doubled the risk (OR, 2.11; 95% CI, 1.34-3.30). Further, combined use of more than 1 antidepressant from different classes more than tripled the risk (OR, 3.51; 95% CI 2.20-5.61). The risk of miscarriage associated with use of these categories of antidepressants was significantly higher than with solo therapy with tricyclic antidepressants or other classes of antidepressants (adjusted OR, 1.27-1.53; P<.05).
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Trimethoprim–sulfamethoxazole not found to increase infant birth weight in HIV cases
July 9th 2025A recent randomized trial found no significant improvement in birth weight or key birth outcomes from antenatal trimethoprim–sulfamethoxazole prophylaxis in human immunodeficiency virus-positive pregnant women.
Read More